We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

114 hedge funds and large institutions have $430M invested in Five Prime Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $2.14M | Put options by funds: $1.66M

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

7% less funds holding

Funds holding: 123 → 114 (-9)

12% less capital invested

Capital invested by funds: $490M → $430M (-$60.7M)

33% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 27

Holders
114
Holders Change
-9
Holders Change %
-7.32%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
41
Reduced
34
Closed
27
Calls
$2.14M
Puts
$1.66M
Net Calls
+$488K
Net Calls Change
+$127K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$33.5M
2
GPP
Great Point Partners
Connecticut
+$5.77M
3
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$4.02M
4
OAM
Oxford Asset Management
United Kingdom
+$3.79M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.5M
2
Victory Capital Management
Victory Capital Management
Texas
-$17.4M
3
BB
BB Biotech
Switzerland
-$15.5M
4
State Street
State Street
Massachusetts
-$5.72M
5
AIM
ARK Investment Management
Florida
-$2.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.65M +$218K +14,660 +8%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.4M +$180K +12,076 +8%
Prudential Financial
28
Prudential Financial
New Jersey
$2.32M +$368K +24,760 +17%
Renaissance Technologies
29
Renaissance Technologies
New York
$2.09M -$1.1M -73,800 -33%
Millennium Management
30
Millennium Management
New York
$1.99M -$2.42M -162,715 -53%
BIM
31
Bogle Investment Management
Massachusetts
$1.89M +$1.55M +104,051 +325%
VIA
32
Vident Investment Advisory
Georgia
$1.85M -$132K -8,882 -6%
PIM
33
Platinum Investment Management
Australia
$1.69M +$407K +27,376 +29%
WC
34
Wexford Capital
Florida
$1.57M +$1.68M +112,700 New
Squarepoint
35
Squarepoint
New York
$1.37M +$881K +59,255 +151%
Bank of America
36
Bank of America
North Carolina
$1.35M -$63.1K -4,243 -4%
AGA
37
Altrinsic Global Advisors
Connecticut
$1.25M – – –
TCIM
38
TIAA CREF Investment Management
New York
$938K -$26.2K -1,762 -3%
Morgan Stanley
39
Morgan Stanley
New York
$923K -$501K -33,681 -34%
AA
40
ALPS Advisors
Colorado
$876K +$177K +11,871 +23%
Swiss National Bank
41
Swiss National Bank
Switzerland
$827K – – –
WBC
42
Westpac Banking Corp
Australia
$762K +$814K +54,715 New
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$758K +$156K +10,457 +24%
Citigroup
44
Citigroup
New York
$745K +$502K +33,741 +171%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$710K +$3.44K +231 +0.5%
AllianceBernstein
46
AllianceBernstein
Tennessee
$695K – – –
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$672K -$522K -35,107 -42%
HH
48
Hilltop Holdings
Texas
$554K -$381K -25,651 -39%
Barclays
49
Barclays
United Kingdom
$534K +$499K +33,584 +704%
Invesco
50
Invesco
Georgia
$527K +$446 +30 +0.1%
1
2
3 4 5

FPRX Hedge Fund Activity: Q3 2018 in Review

114 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2018, worth a combined $430M — down 12% from $490M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of FPRX and 18 opened new positions — a net loss of 9 holders — while 34 trimmed existing stakes and 41 added.

The largest buyer was BVF Inc, adding an estimated $33.5M. The largest seller was Fidelity Investments, cutting an estimated $18.5M.

  • 114 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2018, down from 123 in Q2 2018.
  • Funds reported $430M of Five Prime Therapeutics, Inc. stock for Q3 2018, down 12% quarter-over-quarter.
  • 18 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2018 and 27 closed out, a net change of -9 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q3 2018 was BVF Inc, an estimated $33.5M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q3 2018 was Fidelity Investments, an estimated $18.5M sold.

Based on aggregated 13F filings for Q3 2018.